Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016

MMWR. Morbidity and Mortality Weekly Report
Snigdha VallabhaneniTom M Chiller

Abstract

Candida auris, an emerging fungus that can cause invasive infections, is associated with high mortality and is often resistant to multiple antifungal drugs. C. auris was first described in 2009 after being isolated from external ear canal discharge of a patient in Japan (1). Since then, reports of C. auris infections, including bloodstream infections, have been published from several countries, including Colombia, India, Israel, Kenya, Kuwait, Pakistan, South Africa, South Korea, Venezuela, and the United Kingdom (2-7). To determine whether C. auris is present in the United States and to prepare for the possibility of transmission, CDC issued a clinical alert in June 2016 informing clinicians, laboratorians, infection control practitioners, and public health authorities about C. auris and requesting that C. auris cases be reported to state and local health departments and CDC (8). This report describes the first seven U.S. cases of C. auris infection reported to CDC as of August 31, 2016. Data from these cases suggest that transmission of C. auris might have occurred in U.S. health care facilities and demonstrate the need for attention to infection control measures to control the spread of this pathogen.

References

Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
May 20, 2015·Emerging Infectious Diseases·Maha EmaraRitu Bafna
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva

❮ Previous
Next ❯

Citations

Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cornelius J Clancy, M Hong Nguyen
Mar 24, 2017·The American Journal of Nursing·Betsy Todd
May 19, 2017·MMWR. Morbidity and Mortality Weekly Report·Sharon TsayBrendan R Jackson
Jan 6, 2018·The Journal of Antimicrobial Chemotherapy·Matteo BassettiOliver A Cornely
Jan 27, 2018·Journal of Fungi·Ryan KeanGordon Ramage
Mar 31, 2018·Antimicrobial Resistance and Infection Control·Marie-Elisabeth BougnouxJean-Ralph Zahar
Nov 17, 2017·Clinical Microbiology Reviews·Anna Jeffery-SmithColin S Brown
Jun 8, 2018·Current Opinion in Infectious Diseases·Katja SarisAndreas Voss
Aug 7, 2018·Hospital Practice·Joana AlvesJordi Rello
Jun 7, 2017·Antimicrobial Agents and Chemotherapy·Alexander J LepakDavid R Andes
May 10, 2017·Antimicrobial Agents and Chemotherapy·Elizabeth L BerkowShawn R Lockhart
Oct 4, 2018·The New England Journal of Medicine·David W EyreKatie J M Jeffery
Nov 21, 2017·F1000Research·Anna SkiadaMaria Drogari-Apiranthitou
Feb 15, 2019·Journal of Chemotherapy·Peral JoséRafael Zaragoza
Feb 16, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·William A RutalaDavid J Weber
Jun 14, 2018·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Yuman LeeSagar Viramgama
Dec 7, 2017·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Emil P LeshoEdward E Walsh
May 23, 2019·Journal of Occupational and Environmental Hygiene·Steven R TorresMagdia De Jesus
Jun 5, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Michael H WoodworthCharles Langelier
Jun 11, 2019·Emerging Microbes & Infections·Scott C RobertsBabafemi O Taiwo
Jul 5, 2019·Journal of Medical Microbiology·David RomeraJaime Esteban
Jul 30, 2019·Annals of Internal Medicine·Snigdha VallabhaneniTom M Chiller
Aug 9, 2017·Journal of Clinical Immunology·Kathleen E SullivanMimi L K Tang
Aug 8, 2017·Expert Review of Anti-infective Therapy·Bhagyashri D NavalkelePranatharthi Chandrasekar
Jan 6, 2018·The Journal of Antimicrobial Chemotherapy·Frederic LamothThierry Calandra
Jun 7, 2019·Archives of Pathology & Laboratory Medicine·D Jane HataUNKNOWN College of American Pathologists Microbiology Committee
Dec 18, 2019·Antimicrobial Agents and Chemotherapy·Nathan P WiederholdThomas F Patterson
Aug 21, 2019·Antimicrobial Agents and Chemotherapy·Nathan P WiederholdThomas F Patterson
Sep 6, 2018·Antimicrobial Agents and Chemotherapy·Alexander J LepakDavid R Andes
Jan 10, 2018·Antimicrobial Agents and Chemotherapy·Christopher L HagerMahmoud A Ghannoum
Apr 16, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Massimo PacilliStephanie R Black
May 5, 2020·Journal of Biomedical Materials Research. Part a·Noel Vera-GonzálezAnita Shukla
Jun 21, 2019·BMC Infectious Diseases·Caroline MasloJennifer Coetzee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Minnesota Medicine
Edwin C PereiraRuth Lynfield
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
International Journal of Aging & Human Development
Abigail M Nehrkorn
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
© 2021 Meta ULC. All rights reserved